Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
HSE SummitWebinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory
Commentaries

Subscribe

  • News
  • Watch
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Commentaries
  • Subscribe
  • ADHD
  • Acute Pain
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hidradenitis Suppurativa
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Metabolic Dysfunction-Associated Steatohepatitis
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type 2 Diabetes
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
PBMI 2026|
PBMI Innovators|
AIDS 2026|
State of the Industry survey: Share your 2027 outlook
Advertisement

John Marchisin

Advertisement

Articles by John Marchisin

Schedule

Dynamic Schedule Process Benefits Hospitals, Providers, and Patients

ByJohn Marchisin,Steven Nemerson
February 20th 2020

Inaccurate forecasting of the time needed with patients can result in many negative effects, starting with a basic inability to accommodate for individual patient variability. 

Data logos

Can Data Analytics Lower Hospital-Acquired Condition Incidence?

ByMichael Kim,John Marchisin
September 18th 2019

HACs continue to burden the healthcare system.

Advertisement

Latest Updated Articles

  • Data logos
    Can Data Analytics Lower Hospital-Acquired Condition Incidence?

    September 18th 2019

  • Schedule
    Dynamic Schedule Process Benefits Hospitals, Providers, and Patients

    February 20th 2020



Advertisement
Advertisement

Trending on Managed Healthcare Executive

1

Apothecary Pharma recalls compounded tirzepatide and NAD+ vials over sterility concerns

2

For bronchiectasis, a new era of guideline-guided care | CHEST 2026

3

Now is the time to get ready for 2027 changes in prior authorization, MA Star Ratings and others in federal healthcare law and regulations

4

Jessica Castle, M.D., discusses CGM’s A1C impact in non-insulin type 2 diabetes

5

International guidance and new European data back type 1 diabetes screening for all children

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Formulary Watch
  • Pharmacy Benefit Management Institute
Managed Healthcare Executive
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us